Joana Sousa-Pereira
Braga, 4710057, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Differential effects of lifespan-extending genetic manipulations in an animal model of MJD/SCA3.
Journal: Mechanisms of ageing and development
Published: February 27, 2025
Allosteric Modulation of Pathological Ataxin-3 Aggregation: A Path to Spinocerebellar Ataxia Type-3 Therapies.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 05, 2025
Allosteric Modulation of Pathological Ataxin-3 Aggregation: A Path to Spinocerebellar Ataxia Type-3 Therapies.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Therapeutic Effects of Hemerocallis citrina Baroni Extract on Animal Models of Neurodegenerative Diseases Through Serotonin and HLH-30/TFEB-Dependent Mechanisms.
Journal: International journal of molecular sciences
Published: January 15, 2025
Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 07, 2024
Learning the Biochemical Basis of Axonal Guidance: Using Caenorhabditis elegans as a Model.
Journal: Biomedicines
Published: June 01, 2023
Neurodifferentiation and Neuroprotection Potential of Mesenchymal Stromal Cell-Derived Secretome Produced in Different Dynamic Systems.
Journal: Biomedicines
Published: January 31, 2023
Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3.
Journal: The Journal of clinical investigation
Published: May 31, 2022
Aripiprazole Offsets Mutant ATXN3-Induced Motor Dysfunction by Targeting Dopamine D2 and Serotonin 1A and 2A Receptors in C. elegans.
Journal: Biomedicines
Published: December 31, 2021
Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease.
Journal: Cytotherapy
Published: January 14, 2021
Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease.
Journal: Neurobiology of disease
Published: October 27, 2020
Loss of egli-1, the Caenorhabditis elegans Orthologue of a Downstream Target of SMN, Leads to Abnormalities in Sensorimotor Integration.
Journal: Molecular neurobiology
Published: March 11, 2019
Last Updated: 09/26/2026